The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zabolotnaya S.V.

Federal Center of Brain Research and Neurotechnologies

Bogolepova A.N.

Pirogov Russian National Research Medical University;
Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency

Tairova R.T.

Federal Center of Brain Research and Neurotechnologies

COVID-19-associated stroke

Authors:

Zabolotnaya S.V., Bogolepova A.N., Tairova R.T.

More about the authors

Read: 4862 times


To cite this article:

Zabolotnaya SV, Bogolepova AN, Tairova RT. COVID-19-associated stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(8‑2):5‑10. (In Russ.)
https://doi.org/10.17116/jnevro20211210825

Recommended articles:
Connectome in stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):46-50
Differentiated approach to cognitive reha­bilitation of patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):5-11
Cognitive impairment in bili­nguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29
Fibrin mono­mer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120

References:

  1. COVID-19 Weekly Epidemiological Update WHO, Edition 44, published 15 June 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&gclid=EAIaIQobChMIh660vJTZ8QIVgZ-yCh2nkQP4EAAYASAAEgIpLvD_BwE
  2. Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P, Boullet A, Doukhi D, Le Guennec L, Godefroy N, Maatoug R, Fossati P, Millet B, Navarro V, Bruneteau G, Demeret S, Pourcher V; CoCo-Neurosciences study group and COVID SMIT PSL study group.COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol. 2020;27(12):2651-2657. https://doi.org/10.1111/ene.14478
  3. Zambreanu L, Lightbody S, Bhandari M, et al. A case of limbic encephalitis associated with asymptomatic COVID-19 infection. J Neurol Neurosurg Psychiatry. 2020;91(11):1229-1230. https://doi.org/10.1136/jnnp-2020-323839
  4. Khoo A, McLoughlin B, Cheema S, et al. Postinfectious brainstem encephalitis associated with SARS-CoV-2. J Neurol Neurosurg Psychiatry. 2020;91(9):1013-1014. https://doi.org/10.1136/jnnp-2020-323816
  5. Gigli GL, Vogrig A, Nilo A, et al. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome. Neurol Sci. 2020;41(12):3391-3394. https://doi.org/10.1007/s10072-020-04787-7
  6. Vogrig A, Gigli GL, Bnà C, Morassi M. Stroke in patients with COVID-19: Clinical and neuroimaging characteristics. Neurosci Lett. 2021;743:135564. https://doi.org/10.1016/j.neulet.2020.135564
  7. Mao L, Jin H, Wang M, Hu Y, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690.  https://doi.org/10.1001/jamaneurol.2020.1127
  8. Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. Engl J Med. 2020;382(23):2268-2270. https://doi.org/10.1056/NEJMc2008597
  9. Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767-783.  https://doi.org/10.1016/S1474-4422(20)30221-0
  10. Yaghi S, Ishida K, Torres J, et al. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;51(7):2002-2011. https://doi.org/10.1161/STROKEAHA.120.030335
  11. Nannoni S, de Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. Int J Stroke. 2021;16(2):137-149.  https://doi.org/10.1177/1747493020972922
  12. Valderrama EV, Humbert K, Lord A, Frontera J, Yaghi S. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke. Stroke. 2020;51(7):124-127.  https://doi.org/10.1161/STROKEAHA.120.030153
  13. South KE, Klingenberg B, Leininger EC. A novel degree of sex difference in laryngeal physiology of Xenopus muelleri: behavioral and evolutionary implications. J Exp Biol. 2021;224(7):jeb231712. https://doi.org/10.1242/jeb.231712
  14. Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183(1):16-27.e1.  https://doi.org/10.1016/j.cell.2020.08.028.
  15. Iba T, Levy JH, Connors JM, et al. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24(1):360.  https://doi.org/10.1186/s13054-020-03077-0
  16. Allegra A, Di Gioacchino M, Tonacci A, et al. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications. Int J Mol Sci. 2020;21(13):4782. https://doi.org/10.3390/ijms21134782
  17. Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M; Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019;17(11):1989-1994. https://doi.org/10.1111/jth.14578
  18. Spence JD, de Freitas GR, Pettigrew LC, et al. Mechanisms of Stroke in COVID-19. Cerebrovasc Dis. 2020;49(4):451-458.  https://doi.org/10.1159/000509581
  19. Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889-891.  https://doi.org/10.1136/jnnp-2020-323586
  20. Cheng R, Leedy D. COVID -19 and acute myocardial injury: the heart of the matter or an innocent bystander? Heart. 2020;106(15):1122-1124. https://doi.org/10.1136/heartjnl-2020-317025
  21. Morassi M, Bigni B, Cobelli M, et al. Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence J Neurol. 2020;267(10):2812-2814. https://doi.org/10.1007/s00415-020-09984-0
  22. Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22.  https://doi.org/10.1016/j.bbi.2020.03.031
  23. Baig AM. Neurological manifestations in COVID-19 caused by SARS-CoV-2. CNS Neurosci Ther. 2020;26(5):499-501.  https://doi.org/10.1111/cns.13372
  24. Carod-Artal FJ. Neurological complications of coronavirus and COVID-19. Rev Neurol. 2020;70(9):311-322.  https://doi.org/10.33588/rn.7009.2020179
  25. Orozco-Hernández JP, Marin-Medina DS, Sánchez-Duque JA. Neurological manifestations of SARS-CoV-2 infection. Semergen. 2020;46(suppl 1):106-108.  https://doi.org/10.1016/j.semerg.2020.05.004
  26. Cheng H, Wang Y, Wang GQ. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19. J Med Virol. 2020;92(7):726-730.  https://doi.org/10.1002/jmv.25785
  27. Conklin J, Frosch MP, Mukerji S, et al. Cerebral Microvascular Injury in Severe COVID-19. medRxiv. 2020:2020.07.21.20159376. https://doi.org/10.1101/2020.07.21.20159376
  28. Morassi M, Bagatto D, Cobelli M, et al. Stroke in patients with SARS-CoV-2 infection: case series. J Neurol. 2020;267(8):2185-2192. https://doi.org/10.1007/s00415-020-09885-2
  29. Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA, et al. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain. 2020;143(10):3089-3103. https://doi.org/10.1093/brain/awaa239
  30. Vogrig A, Bagatto D, Gigli GL, et al. Causality in COVID-19-associated stroke: a uniform case definition for use in clinical research. J Neurol. 2020;1(Aug):1-4.  https://doi.org/10.1007/s00415-020-10103-2
  31. Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91:889-891.  https://doi.org/10.1136/jnnp-2020-323586]
  32. Siow I, Lee KS, Zhang JJY, et al. Stroke as a Neurological Complication of COVID-19: A Systematic Review and Meta-Analysis of Incidence, Outcomes and Predictors. J Stroke Cerebrovasc Dis. 2021;30(3):105549. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105549
  33. Ntaios G, Michel P, Georgiopoulos G, et al. Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry. Stroke. 2020;51(9):254-258.  https://doi.org/10.1161/STROKEAHA.120.031208
  34. Tan YK, Goh C, Leow AST, et al. COVID -19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020;50(3):587-595.  https://doi.org/10.1007/s11239-020-02228-y
  35. John S, Kesav P, Mifsud VA, et al. Characteristics of Large-Vessel Occlusion Associated with COVID-19 and Ischemic Stroke. Am J Neuroradiol. 2020;41(12):2263-2268. https://doi.org/10.3174/ajnr.A6799
  36. Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382(20):e60.  https://doi.org/10.1056/NEJMc2009787
  37. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-847.  https://doi.org/10.1111/jth.14768
  38. Katz JM, Libman RB, Wang JJ, et al. Cerebrovascular complications of COVID-19. Stroke. 2020;51:227-231.  https://doi.org/10.1161/STROKEAHA.120.031265
  39. Cappellari M, Zini A, Sangalli D, et al. Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid-19. Eur J Neurol. 2020;27(12):2641-2645. https://doi.org/10.1111/ene.14511
  40. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Latin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19). Electronic address: https://doi.org/10.1016/j.tmaid.2020.101623
  41. Girard TD, Thompson JL, Pandharipande PP, et al. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study. Lancet Respir Med. 2018;6(3):213-222.  https://doi.org/10.1016/S2213-2600(18)30062-6
  42. Baker HA, Safavynia SA, Evered LA. The ‘third wave’: impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth. 2021;126(1):44-47.  https://doi.org/10.1016/j.bja.2020.09.045

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.